Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid

Bibliographic Details
Title: Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid
Authors: Yu-Hsin Chu, Yi-Chen Huang, Pei-Yun Chiu, Wen-Hung Kuo, Yan-Ru Pan, Yuan-Ting Kuo, Rong-Hsuan Wang, Yu-Chin Kao, Yi-Hsiang Wang, Yi-Fan Lin, Kai-Ti Lin
Source: iScience, Vol 26, Iss 5, Pp 106597- (2023)
Publisher Information: Elsevier, 2023.
Publication Year: 2023
Collection: LCC:Science
Subject Terms: Cancer, Epigenetics, Molecular biology, Science
More Details: Summary: Breast cancer is the leading cause of cancer-related death in women. Among breast cancer types, triple-negative breast cancer (TNBC) accounts for 15% of all breast cancers with aggressive tumor behavior. By using bioinformatic approaches, we observed that the microRNA-708 promoter is highly methylated in breast carcinomas, and this methylation is linked to a poor prognosis. Moreover, microRNA-708 expression correlates with better clinical outcomes in TNBC patients. Combination treatment with the hypomethylating agent decitabine and synthetic glucocorticoid significantly increased the expression of microRNA-708, reactivated DNMT-suppressed pathways, and decreased the expression of multiple metastasis-promoting genes such as matrix metalloproteinases (MMPs) and IL-1β, leading to the suppression of breast cancer cell proliferation, migration, and invasion, as well as reduced tumor growth and distant metastasis in the TNBC xenograft mouse model. Overall, our study reveals a therapeutic opportunity in which a combined regimen of decitabine with glucocorticoid may have therapeutic potential in treating TNBC patients.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2589-0042
Relation: http://www.sciencedirect.com/science/article/pii/S2589004223006740; https://doaj.org/toc/2589-0042
DOI: 10.1016/j.isci.2023.106597
Access URL: https://doaj.org/article/cc32088b5466443c8efac601d96929a4
Accession Number: edsdoj.32088b5466443c8efac601d96929a4
Database: Directory of Open Access Journals
More Details
ISSN:25890042
DOI:10.1016/j.isci.2023.106597
Published in:iScience
Language:English